A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of the Blood-stage Malaria Candidate Vaccines RH5.1 in Matrix-M and R78C in Matrix-M in Healthy UK Adults
Clinical trial NCT05385471 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05385471
- Sponsor
- University of Oxford
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-13
- Primary completion
- 2026-03-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.